Over the past 12 months, 5 insiders at Calidi Biotherapeutics, Inc. filed 5 open-market SEC Form 4 transactions on CLDI: 4 purchases worth $455K and 1 sale worth $1K. Insiders have been net buyers over this period. The most recent filing was on Dec 12, 25.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 12, 25 | Allan CamaisaDirector | SELL | 850 | $1.46 | $1K |
| Aug 21, 25 | Eric E PomaChief Executive Officer | BUY | 25.0K | $2.00 | $50K |
| Aug 21, 25 | Andrew C. JacksonChief Financial Officer | BUY | 2.5K | $2.00 | $5K |
| Aug 21, 25 | Scott LeftwichDirector | BUY | 125.0K | $2.00 | $250K |
| Aug 21, 25 | James A SchoeneckDirector | BUY | 75.0K | $2.00 | $150K |
| Dec 17, 24 | Allan CamaisaCEO and Chairman of the Board | SELL | 10.0K | $1.62 | $16K |
Over the past 12 months, insiders at Calidi Biotherapeutics, Inc. filed 4 open-market purchases worth $455K and 1 sale worth $1K on CLDI, which makes them net buyers over the period. The most recent Form 4 was filed on Dec 12, 25.
The largest recent open-market CLDI insider purchase in our data was $250K by Scott Leftwich, Director, filed on Aug 21, 25.
5 different insiders at Calidi Biotherapeutics, Inc. filed open-market SEC Form 4 transactions on CLDI over the last 12 months.
InsiderTape plots every CLDI insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Calidi Biotherapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →